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Relevance:
To increase the number of organ donors in England, the government will implement 
Max and Keira’s Law: all adults over the age of 18 living in the United Kingdom become 
potential organ donors a!er their death, unless they choose to opt out. The law will be 
employed by spring 2020. Despite there being presumed consent for the retrieval of organs, 
families of the deceased will still be contacted to recheck consent, and ensure that family 
wishes are upheld.
Summary:
 
Despite de"nite implementation of the law, there have been concerns over the presumed 
consent given for retrieving organs from the deceased; ignorance and lethargy from certain 
members of the public may mean that true informed consent can never be obtained when 
collecting organs. To combat this, expensive national campaigns would need to be launched 
to make the public aware of the new process, as well as educating them on how to opt out 
of the process if necessary. Regardless of these challenges, there are many advantages to 
the new law. Advantages include an increase in successful organ donations and transplant, 
as well as potentially an increased availability of organs for use in medical research, drug 
development and university teaching.
Take Home Messages:
Based on the advantages, the move to the opt-out system appears to be a sensible method 
to increase the number of organs available for use in medicine. Proposed alternatives such 
as xenotransplantation and 3D bioprinting have the obvious bene"t of providing an almost 
in"nite supply of organs. However, these alternatives remain in the preclinical stages, with 
ethical challenges and infection risks that need to be overcome before they can be used in 
hospitals. 
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By Spring 2020, the UK government will implement ‘Max and 
Keira’s Law, commonly referred to as an opt-out system. Everyone 
over the age of 18 in England will be assumed to have agreed to 
be an organ donor when they die. (1) The new system would not 
presume consent for the retrieval of organs whilst a person is still 
alive; however, individuals may still opt to be a living donor. All 
adults living in England will be on the organ donor list unless they 
have opted out by recording their decision not to donate, or are 
a part of a group excluded from organ donors. Excluded groups 
would include those who have or are suspected of having conditions 
such Creutzfeldt-Jakob Disease (CJD), Ebola, an active malignancy 
or are HIV positive. (2)
Currently, all countries within the UK except Wales have an opt-in 
system, where people are not considered as organ donors unless they 
sign up to the register, and express consent to donate. The opt-out 
legislation, which was "rst proposed in 2015, has been supported 
by several health regulatory bodies in the UK, most notably from 
the British Medical Association (BMA), who have supported the 
change by advising local MPs through parliamentary brie"ngs about 
the positive impact that this life-saving change in law could bring. 
(3) Those excluded from having given assumed consent include 
minors, those who lack the mental capacity to understand and act 
on the new law, visitors to England and those who have lived in 
England for less than 12 months prior their death. Moreover, if a 
deceased individual has not opted out, family members will still be 
contacted and asked if they knew of any unregistered objection. (4) 
If there is a known objection from the deceased, or it becomes clear 
that the individual would not have consented, the organ donation 
will not go ahead; donation despite objections would ruin the trust 
between a doctor and the family and could reduce donation rates 
in the long term. Organ donation involves legal consent from the 
donor, which can be obtained when the donor is alive or dead with 
the assent of their next of kin. (5) Donation may be for research 
or transplantation into another person as a part of an operation to 
either save or improve the recipient’s quality of life. 
The main aim of an opt-out system is to overcome the shortage 
of organ donors currently available for transplant operations in the 
UK. Statistics taken from the 31st March 2019 show that there were 
6077 patients in the UK waiting for a suitable organ on the active 
transplant list, yet only 1600 deceased donors listed in the UK. A 
further 1039 living donors are also listed. (6) Although it is possible 
for a single donor to donate multiple organs, the demand for certain 
organs over others, such as a demand for kidney and liver donors, 
would limit the number of organs retrieved per donor. In cases 
where an organ is available, challenges such as family refusal, poor 
condition of a donated organ, incorrect blood type or tissue match 
and adverse immune reactions leading to the body’s rejection of an 
organ, may prevent a successful transplantation.
The proposed system would generate a greater number of potential 
organ donors, leading to a larger selection of organs that surgeons 
can use in operations, thus increasing the likelihood of "nding a 
suitable match for someone who needs a transplant. (7) This could 
lead to a reduction of complications post-surgery, which bene"ts 
both the patient’s health and the NHS "nancially, as less money 
would be spent in treating the complications of surgery, providing 
alternative treatments or arranging palliative care for someone with 
a life-limiting condition. This paper aims to discuss some of the 
advantages, disadvantages and alternatives to the implementation of 
‘Max and Keira’s Law’ in England.
The opt-out organ donation system has already been trialed in 
several European countries, including Austria, France, Greece, 
Italy, Spain and Sweden. Spain has the highest rates of organ 
donation in Europe, due to their implementation of presumed 
consent, along with additional non-legislative measures, such as 
"nancial incentives for those who do not choose to opt out. (8) 
Overall, when other determinants of donation rates are accounted 
for such as GDP per capita, literacy rates, religion and causes of 
death of donors, presumed consent countries have roughly 25–30% 
higher organ donation rates than opt-in countries. (9, 10) 
Not all these countries have opt-out organ donation systems. 
Some countries such as Israel use a donation-allocation system to 
motivate individuals to donate organs. Israel’s Organ Transplant Act 
2008 introduced a priority point system, rewarding those who are 
willing to donate an organ with preferential status as a recipient of a 
donated organ. A person can gain priority points by signing a donor 
card, making an organ donation during their lifetime, being a "rst-
degree relative of someone signing a donor card or by consenting to 
donate organs a!er death. (11) The act has led to a record number 
of signed donor cards and there has been a signi"cant increase in the 
numbers of transplants in Israel.
Perhaps the greatest advantage to an opt-out system is that an 
increase in donated organs available for transplant would lead to 
more successful operations. Successful transplant allows patients 
to have a greater quality of life and return to their normal routine 
prior to their illness. For example, if someone required a kidney 
transplant, but was unable to "nd a suitable donor, they would 
have to undergo haemodialysis for multiple hours weekly. The 
average patient receives dialysis 18 hours a week, which extrapolates 
to the patient losing one month of every year out of their normal 
routine on dialysis alone. (12) Exhausting processes such as dialysis, 
can be eliminated through successful organ transplantation, and 
signi"cantly improve patients’ quality of life.
Organ donation may provide closure and consolation for the family 
of someone who has passed away suddenly or in a tragic manner. 
Normally, families would only be contacted if the deceased had 
signed up to the organ register; however, an opt-out system would 
mean that if the deceased’s organs were needed, the family would 
be contacted in order to seek consent for the organs to be used. 
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Opening this new avenue for families who had not previously 
considered organ donation may provide some relief and alleviate 
their own guilt, as they know that their relative’s death was not in 
vain. 
Further satisfaction could be received as the family of the lost 
individual may also have the chance to connect to new individuals 
who were saved due to the organs of their loved one. A 1987 
descriptive study that examined donor families' overall feelings 
about their organ donation experience found that of the 83% of 
families who returned a survey, a majority of donor families had 
positive feelings about organ donation because of their desire to 
help someone else and make something good come from their 
loss (13). It is important to note that not all families would feel 
consolation knowing that their loved ones’ organs are being used 
to treat another individual. Families may grieve in di#erent ways 
and the idea of organ donation may prolong the family’s grieving 
period. In such cases, it would be important for clinicians to provide 
social and emotional support for families experiencing the organ 
donation process, and communicate sensitively when asking for 
consent. (14, 15)
An opt-out system would increase the number of organs collected 
for medical research or teaching purposes—when an organ is 
unsuitable for transplant or if a speci"c tissue type of organ is 
desired for research. Organ use in research could contribute to 
providing vital information about the pathology of a disease; and 
assist in the development of more e$cacious drugs with improved 
safety pro"les, as they would be tried on a donated organ before 
risking the safety of a participant in a trial. (16) Moreover, due 
to higher volumes of organs available, medical students have the 
potential to learn anatomy and human physiology using human 
specimens. Thereby allowing medical students to forge stronger 
links between anatomy and the pathologies observed during clinical 
placements. (17)
One of the main reasons for organ shortage is due to insu$cient 
education on organ donation. (18) An opt-out system may 
engage the public on the issues surrounding organ donation, 
as the government would accompany the new law with a large 
awareness campaign to educate and assist people in making an 
informed choice. A study analyzing 383 medical students showed 
that prior to a speci"c lecture on organ donation, the request for 
further information about organ donation was signi"cantly higher 
amongst students without a donor card compared to card carriers 
(P < 0.0001). However, a!er the lecture, the number of students 
requiring further information decreased to just 19% of the cohort 
(P < 0.0001). (19)  Exposure to donated organs during teaching, and 
a speci"c lecture about donation signi"cantly decreases the request 
for further information on organ donation and improves students’ 
attitude to organ donation. With such teaching, students could 
share the information with friends, families and colleagues, thus 
helping to reinforce a positive attitude to organ donation from the 
general public. Hence, contribute to fewer people opting-out. (19) 
Though a majority are in favour of organ donation, (20) the 
proposed system relies on the assumption that the public are 
informed about the process, and can decide what happens to their 
organs a!er death. This ignores the possibility that some members 
of the public remaining ignorant or lethargic with regards to "nding 
out about donation; some would still be accustomed to a process 
where consent is given actively, rather than as a result of inaction. 
(21) This would ultimately result in several organs being retrieved 
without true informed consent, which may compromise the trust 
patients have in doctors and the NHS. 
To ensure that most organs are donated with true informed 
consent, the government would have to spend more educating the 
public via national campaigns. In 2016-2017, the NHS Blood and 
Transplant (NHSBT) spent approximately £5 million on campaigns 
encouraging mainly those who are less aware of the need and the 
opportunity to save lives to donate. (22) A change in systems would 
mean that the NHSBT would have to spend a greater sum annually 
to address the entire population, rather than just targeted groups. 
The public would need to be informed that they are organ donors 
by default, and would need to be given the relevant information on 
how to remove themselves from the register if they choose to opt 
out. This information is too vast to be conveyed solely via social 
media; more expensive traditional media campaigns and expensive 
television and print advertising would be required. Therefore, 
requiring a larger budget to be allocated to the NHSBT from the 
government. 
Another concern regarding the shi! to an opt-out system is that 
an increased rate of organ donation does not necessarily equate 
to a proportional increase in successful organ/tissue transplants. 
Conditions such as osteopenia, obesity (due to inactivity/diet 
changes), cancer and autoimmune tissue rejection could develop 
in individuals a!er a transplant, and would negatively impact an 
individual’s quality of life. (23) A study measuring the incidence 
of malignant tumours post-transplant operation showed that out 
of 674 solid-organ-transplant recipients (305 renal, 307 heart, 54 
lung, 8 heart/lung), 79 malignancies were detected, representing 
an overall cancer frequency of 11.7% in recipients of organs which 
would further complicate their health. (24) Therefore, it could be 
argued that rather than shi! to an opt-out system, the NHS should 
instead focus on preventing post-operation complications, and 
providing further care for organ recipients post-transplant.
As the opt-out system has already been accepted and will be 
enforced in the UK, future discussions will likely turn to how the 
new law can be successfully implemented, rather than whether 
the law is needed in the "rst place. Nonetheless, it is still worth 
exploring some of the more unfamiliar alternatives to organ 
donation such as xenotransplantation, genetic engineering and 
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3D Bioprinting organ tissue. All three alternatives o#er an almost 
unlimited source of organs. Scheduling transplant surgery would 
no longer be dependent on the unpredictable availability of a donor 
human organ. This would allow clinicians to intentionally time 
the harvesting of an organ for immediate transplantation, as well as 
allocate immunologic pre-treatment of the recipient if necessary. 
(25) 
Xenotransplantation involves transplanting tissues or organs 
between members of di#erent species. Most xenotransplantation 
activity is still in the preclinical stage. Currently, there are 
signi"cant ethical concerns surrounding xenotransplantation 
as it could mean livestock would be reared solely for organ 
harvesting, as well as the threat of spread of infectious diseases. 
Xenotransplantation would be accompanied with heavy 
immunosuppressive therapy, which can lead to fatal infections such 
as Hepatitis B and HIV in patients. (26) These challenges would 
have to be overcome before xenotransplantation can compete with 
organ donation.
A printed organ is an arti"cially constructed structure designed for 
organ replacement, produced using 3D bioprinting techniques. 
3D bioprinting seems to be a feasible alternative compared 
to xenotransplantation. However, 3D bioprinting is relatively 
expensive due to a lack of equipment and resources, and needs to 
be further developed before it can be commonly used in hospitals. 
Another option is genetic engineering. Genetic engineering 
involves the modi"cation of the phenotype of a living organism 
by manipulating its genetic material.  The exact tissue type and 
blood type of an organ can be engineered, resulting in a much 
lower chance of rejection by the body of the recipient. (27) Since 
no humans or animals are used to obtain the organ, there are fewer 
ethical di$culties that need to be overcome when using genetic 
engineering. However, practicality and expense still remain an 
issue. 
The UK’s move to an opt-out system in 2020 means that all 
adults over the age of 18 living in the UK become potential organ 
donors a!er their death. Despite there being presumed consent 
for the retrieval of organs, families of the deceased will still be 
contacted to recheck consent and ensure that family wishes are 
upheld. Challenges to this new system include the possibility of true 
informed consent never being fully achieved. Advantages include 
an increase in successful organ donation and transplantation, as well 
as potentially an increased availability of organs for use in medical 
research, drug development and medical teaching. Based on the 
potential bene"ts, as well as the fact that proposed alternatives to 
organ donation are still in the preclinical stages, the move to the 
opt-out system appears to be a sensible method to increase the 
number of organs available for use in medicine.
Summary:
• The opt-out system will be implemented in Spring 2020 by in 
England.
• Those over 18 will be assumed to have given consent to be an 
organ donor unless they have opted out or are part of a group 
excluded from organ donation. 
• The main aim of an opt-out system is to increase the number of 
organ donors available for transplant in UK.
• Countries with opt-out systems have around 25-30% higher 
donation rates than opt-in countries.
• Opt-out systems may also help facilitate research and teaching, 
providing information about pathology of a disease and drug 
development. 
• Challenges of an opt-out system involve lack of true informed 
consent due to members of the public remaining ignorant or 
lethargic with regards to "nding out about donation.
• Increased rate of organ donation does not always mean the 
number of successful organ and tissue transplants increase.
• Alternatives to an opt-out system include xenotransplantation, 
genetic engineering and 3D printing. 
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